lation in its western-most quarterrelies on groundwater for drink-ing water. In addition, highly con-sumptive uses, such as agriculturalirrigation are increasing.2From 1985 through 1988, whenprecipitation statewide was 75percent of normal and streamflowhalf of normal, serious declines inwater quality occurred leading toemergency measures to allocateand conserve, including local banson nonessen
Conversely, injection forms, though being painful and needing help of medical personnel for application, help to quickly achieve necessary concentration of preparation in blood doxycycline online Antibiotic is usually chosen in an empiric way (at random). But when choosing one is obligatory guided by definite rules.
Microsoft word - environmental risk factors.docxENVIRONMENTAL RISK FACTORS FOR THROMBOPHILIA
• Age: Prior to the age of 40 the risk is approximately 1 in 10,000, while after the age of
75, the risk is 1 in 100. This disparity reflects the increased risk of venous thrombosis from acquired conditions and environmental factors that occur with age. • Surgery: Incidence of DVTs in surgical patients varies based on type of surgery from
approximately 6% in general surgery patients to 30% of individuals having knee replacement; these rates significantly increase without optimal thromboprophylaxis (Perry, 2003). • Major trauma: Incidence of DVTs among patients with major trauma exceeds 50%;
independent risk factors for DVT following trauma include: older age, blood transfusions, surgery, femur or tibia fracture, and spinal cord injury (Perry, 2003). • Periods of immobility: Bed rest, usually defined at ≥ 3 days in bed, long periods of
travel, usually defined at > 4-5 hours, or a sedentary lifestyle (Varga, 2007). • Cancer: Malignancies, especially adenocarcinomas, brain tumors, and myeloproliferative
disorders, are associated with thrombotic complications; chemotherapy also increases the risk for VTEs. • Oral contraceptives: Higher estrogen content and third-generation progestins are
associated with a greater increased risk for DVTs than lower estrogen and second-generation progestins (Perry, 2003). • Pregnancy and post-partum period: Pregnant women have a 5 times higher risk for
VTEs than non-pregnant women. The risk for DVT’s increases throughout pregnancy, with the greatest risk occurring during the third trimester (Friederich, 1996). • Hormone replacement therapy: Amount of increased risk depends on duration of
treatment, dosage, and the hormones that are used. • Selective estrogen receptor modulators (i.e. Tamoxifen & raloxifene): One study found
the overall relative risk for DVT while taking tamoxifen is 1.6 and the overall relative risk of sustaining a VTE while taking raloxifene is 3.1 (Cummings, 1999). • Smoking: Increases the risk for pulmonary embolisms more so than the risk for VTEs.
• Specific Medical Conditions: Conditions that interfere with blood flow (atrial
fibrillation), damage blood vessles (diabetes and hypertension), and affect blood chemistry (cancer, inflammatory bowel disease, obesity, or lupus) increase the risk for VTEs. References:
Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC (1999) The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 281:2189-97. Friederich PW, Sanson BJ, Simioni P, Zanardi S, Huisman MV, Kindt I, et al. (1996) Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Intern Med 125:955-960. ENVIRONMENTAL RISK FACTORS FOR THROMBOPHILIA
Perry SL, Ortel TL. (2003) Clinical and laboratory evaluation of thrombophilia. Clin Chest Med 24:153-170. Varga, Elizabeth. (2007) Inherited thrombophilia: Key points for genetic counseling. J Genet Counsel;16(3):261-77.
Therapeutic Advances in Infectious Disease : the need to study case reports W. Victor R. Vieweg, Jules C. Hancox, Mehrul Hasnain, Jayanthi N. Koneru, Michael Gysel and Adrian Baranchuk Therapeutic Advances in Infectious Disease The online version of this article can be found at: can be found at: Therapeutic Advances in Infectious Disease Additional services and information for